JCI - Citations to T cell control in autoimmune bullous skin disorders

Citations to this article

T cell control in autoimmune bullous skin disorders

Michael Hertl, … , Rüdiger Eming, Christian Veldman

Michael Hertl, … , Rüdiger Eming, Christian Veldman

Published May 1, 2006
Citation Information: J Clin Invest. 2006;116(5):1159-1166. https://doi.org/10.1172/JCI28547.

View: Text | PDF

Total citations by year

Year:	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2002	1985	Total
Citations:	4	5	4	9	4	8	7	3	11	10	4	4	3	11	9	15	11	12	4	1	1	1	141

Citation information

Citations to this article (141)

Title and authors	Publication	Year
New Onset and Exacerbation of Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Systematic Review Wu PC, Huang IH, Wang CY, Chi CC	Human vaccines	2024
A Comprehensive Review on the Intricate Interplay between COVID-19 Immunization and the New Onset of Pemphigus Foliaceus Bălăceanu-Gurău B, Dumitrascu A, Giurcăneanu C, Tatar R, Gurău CD, Orzan OA	Vaccines	2024
HLA-Cw6 Polymorphism in Autoimmune Blistering Diseases Ciolfi C, Sernicola A, Alaibac M	Biomolecules	2024
Oral mucosal lesions in the mouth as first sign of dermatological diseases and disorders Karthikeyini HM, Shunmugavelu K, Dhinakaran EC	GMS Hygiene and Infection Control	2024
Researching trends in pemphigoid diseases: A bibliometric study of the top 100 most cited publications Huang SC, Chiu TM, Lee CY, Chang HC, Wu WJ, Gau SY	Frontiers in Medicine	2023
The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets Maglie R, Solimani F, Didona D, Pipitò C, Antiga E, Di Zenzo G	Frontiers in Medicine	2023
Skin-infiltrating T cells display distinct inflammatory signatures in lichen planus, bullous pemphigoid and pemphigus vulgaris Schinner J, Cunha T, Mayer JU, Hörster S, Kind P, Didona D, Keber C, Hertl M, Worzfeld T, Juratli HA	Frontiers in immunology	2023
HLA class II antigens in Croatian patients with pemphigus vulgaris and their correlation with anti-desmoglein antibodies Lakoš Jukić I, Mokos M, Marinović B	Frontiers in immunology	2023
Role of Human Leukocyte Antigen Class II in Antibody-Mediated Skin Disorders Sernicola A, Mazzetto R, Tartaglia J, Ciolfi C, Miceli P, Alaibac M	Medicina	2023
FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus Maho-Vaillant M, Sips M, Golinski ML, Vidarsson G, Goebeler M, Stoevesandt J, Bata-Csörgő Z, Balbino B, Verheesen P, Joly P, Hertl M, Calbo S	Frontiers in immunology	2022
Association of specific HLA alleles and haplotypes with pemphigus vulgaris in the Bulgarian population. Drenovska K, Ivanova M, Vassileva S, Shahid MA, Naumova E	Frontiers in immunology	2022
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus. Kridin K, Mruwat N, Ludwig RJ		2022
Expression of the Selected Proteins of JAK/STAT Signaling Pathway in Diseases with Oral Mucosa Involvement Ociepa K, Danilewicz M, Wągrowska-Danilewicz M, Peterson-Jęckowska R, Wójcicka-Rubin A, Lewkowicz N, Zajdel R, Żebrowska A	International journal of molecular sciences	2022
Detection of autoreactive CD4+ T cells by MHC class II multimers in HLA-linked human autoimmune diseases Michael Hertl	Journal of Clinical Investigation	2021
Human desmocollin 3-specific IgG antibodies are pathogenic in a humanized HLA-class II transgenic mouse model of pemphigus C Hudemann, R Maglie, M Llamazares, B Beckert, D Didona, R Tikkanen, T Schmitt, T Hashimoto, J Waschke, M Hertl, R Eming	Journal of Investigative Dermatology	2021
New-Onset Bullous Pemphigoid in a COVID-19 Patient N Olson, D Eckhardt, A Delano, SA Covarrubias	Case Reports in Dermatological Medicine	2021
Neu aufgetretenes bullöses Pemphigoid bei einer Patientin mit COVID-19 Olson N, Eckhardt D, Delano A		2021
MicroRNAs in pemphigus and pemphigoid diseases C Papara, D Zillikens, CD Sadik, A Baican	Autoimmunity Reviews	2021
Pemphigus: a critical analysis on clinical subtypes, pathogenesis, diagnostics and established novel therapeutics R EMING, CL ZIMMER, M HERTL		2021
Autoreactive T cells in pemphigus: perpetrator and target L SCARSELLA, R POLLMANN, KT AMBER		2021
Autoimmune bullous diseases in pregnancy: clinical and epidemiological characteristics and therapeutic approach PP Fagundes, CG Santi, CW Maruta, D Miyamoto, V Aoki	Anais Brasileiros de Dermatologia	2021
Arginase 1 + IL‐10 + polymorphonuclear myeloid‐derived suppressor cells are elevated in patients with active pemphigus and correlate with an increased Th2/Th1 response D Neri, M CarevicNeri, J Brück, J Holstein, I Schäfer, F Solimani, R Handgretinger, D Hartl, K Ghoreschi	Experimental Dermatology	2021
Bullous pemphigoid caused by contact allergy to bone cement: A case report SM Franken, T Rustemeyer	Contact Dermatitis	2020
Braun-Falco´s Dermatology G Plewig, L French, T Ruzicka, R Kaufmann, M Hertl		2020
The role of T cells in pemphigus vulgaris and bullous pemphigoid H Fang, Q Li, G Wang	Autoimmunity Reviews	2020
Kinetic studies of galectin‐10 release from eosinophils exposed to proliferating T cells C Lingblom, K Andersson, C Wennerås	Clinical & Experimental Immunology	2020
Resolution in bullous pemphigoid CD Sadik, E Schmidt	Seminars in Immunopathology	2019
The pathogenesis of bullous skin diseases M Yang, H Wu, M Zhao, C Chang, Q Lu		2019
Coagulation and Skin Autoimmunity M Cugno, A Borghi, S Garcovich, AV Marzano	Frontiers in immunology	2019
Characteristic Pattern of IL-17RA, IL-17RB, and IL-17RC in Monocytes/Macrophages and Mast Cells From Patients With Bullous Pemphigoid S Nesmond, C Muller, RL Naour, M Viguier, P Bernard, F Antonicelli, SL Jan	Frontiers in immunology	2019
Genetics and Omics Analysis of Autoimmune Skin Blistering Diseases M Olbrich, A Künstner, M Witte, H Busch, A Fähnrich	Frontiers in immunology	2019
Refractory pemphigus foliaceous treated with rituximab F Awdeh, E Gilhooley, CO Grady, M Connolly	BMJ case reports	2019
Oral Manifestation of Paraneoplastic Pemphigus S Kim, IH Park, YJ Park, JS Kwon, J Choi, HJ Ahn	Journal of Oral Medicine and Pain	2019
Refractory pemphigus foliaceous treated with rituximab. Awdeh F, Gilhooley E, O Grady C, Connolly M	BMJ case reports	2019
Th1/Th17 cell recognition of desmoglein 3 and bullous pemphigoid antigen 180 in lichen planus T Schmidt, F Solimani, R Pollmann, R Stein, A Schmidt, I Stulberg, K Kühn, R Eming, V Eubel, P Kind, N Arweiler, C Sitaru, M Hertl	Journal of Allergy and Clinical Immunology	2018
Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches R Pollmann, T Schmidt, R Eming, M Hertl	Clinical Reviews in Allergy & Immunology	2018
The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury H Fang, Y Zhang, N Li, G Wang, Z Liu	Frontiers in immunology	2018
Autoreactive IgG and IgA B Cells Evolve through Distinct Subclass Switch Pathways in the Autoimmune Disease Pemphigus Vulgaris CT Ellebrecht, EM Mukherjee, Q Zheng, EJ Choi, SG Reddy, X Mao, AS Payne	Cell Reports	2018
Association of HLA class I and class II alleles with bullous pemphigoid in Chinese Hans H Fang, S Shen, X Zheng, E Dang, J Zhang, S Shao, P Qiao, Q Li, H Wang, C Li, L Sun, G Wang	Journal of Dermatological Science	2018
The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease KT Amber, M Valdebran, K Kridin, SA Grando	Frontiers in Medicine	2018
Braun-Falco’s Dermatologie, Venerologie und Allergologie G Plewig, T Ruzicka, R Kaufmann, M Hertl		2018
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial P Joly, M Maho-Vaillant, C Prost-Squarcioni, V Hebert, E Houivet, S Calbo, F Caillot, ML Golinski, B Labeille, C Picard-Dahan, C Paul, MA Richard, JD Bouaziz, S Duvert-Lehembre, P Bernard, F Caux, M Alexandre, S Ingen-Housz-Oro, P Vabres, E Delaporte, G Quereux, A Dupuy, S Debarbieux, M Avenel-Audran, M D'Incan, C Bedane, N Bénéton, D Jullien, N Dupin, L Misery, L Machet, M Beylot-Barry, O Dereure, B Sassolas, T Vermeulin, J Benichou, P Musette	The Lancet	2017
T regulatory cells and other lymphocyte subsets in patients with bullous pemphigoid T Gambichler, A Tsitlakidon, M Skrygan, S Höxtermann, L Susok, S Hessam	Clinical and Experimental Dermatology	2017
Glucocorticoids: The mode of action in bullous pemphigoid ME Kubin, L Hellberg, R Palatsi	Experimental Dermatology	2017
Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris AS Lo, X Mao, EM Mukherjee, CT Ellebrecht, X Yu, MR Posner, AS Payne, LA Cavacini, A Kumar	PloS one	2016
Induction of T regulatory cells by the superagonistic anti-CD28 antibody D665 leads to decreased pathogenic IgG autoantibodies against desmoglein 3 in a HLA-transgenic mouse model of pemphigus vulgaris T Schmidt, S Willenborg, T Hünig, CA Deeg, G Sonderstrup, M Hertl, R Eming	Experimental Dermatology	2016
Schleimhautbeteiligung bei blasenbildenden Autoimmunerkrankungen C Günther	Der Hautarzt	2016
Familial Pemphigus Vulgaris Occured in a Father and Son as the First Confirmed Cases AH Eskiocak, B Ozkesici, S Uzun	Case Reports in Dermatological Medicine	2016
Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus T Hennerici, R Pollmann, T Schmidt, M Seipelt, B Tackenberg, C Möbs, K Ghoreschi, M Hertl, R Eming, Y Richard	PloS one	2016
Inzidenz von bullösen Autoimmunerkrankungen in Serbien: eine retrospektive Studie über 20 Jahre: Inzidenz von bullösen Autoimmunerkrankungen M Milinković, S Janković, L Medenica, M Nikolić, V Reljić, S Popadić, J Janković	JDDG Journal der Deutschen Dermatologischen Gesellschaft	2016
The Prevalence of S. aureus Skin and Soft Tissue Infections in Patients with Pemphigus ZF Aghmiyuni, A Khorshidi, R Moniri, T Soori, SG Musavi	Autoimmune Diseases	2016
Incidence of autoimmune bullous diseases in Serbia: a 20-year retrospective study: Incidence of autoimmune bullous diseases MV Milinković, S Janković, L Medenica, M Nikolić, V Reljić, S Popadić, J Janković	JDDG Journal der Deutschen Dermatologischen Gesellschaft	2016
Validation studies of outcome measures in pemphigus S Hanna, M Kim, DF Murrell	International Journal of Women's Dermatology	2016
Braun-Falco's Dermatologie, Venerologie und Allergologie G Plewig, T Ruzicka, R Kaufmann, M Hertl	Braun-Falco's Dermatologie, Venerologie und Allergologie	2016
The Prevalence of S. aureus Skin and Soft Tissue Infections in Patients with Pemphigus ZF Aghmiyuni, A Khorshidi, R Moniri, T Soori, SG Musavi	Autoimmune Diseases	2016
Bullous pemphigoid: What's ahead? M Furue, T Kadono	The Journal of Dermatology	2015
Immune response in pemphigus and beyond: progresses and emerging concepts GD Zenzo, KT Amber, BS Sayar, EJ Müller, L Borradori	Seminars in Immunopathology	2015
Pemphigus: Modellerkrankung für zielgerichtete Therapien R Eming	Der Hautarzt	2015
T cell participation in autoreactivity to NC16a epitopes in bullous pemphigoid: T cells and Nc16a epitopes in bullous pemphigoid WJ Pickford, V Gudi, AM Haggart, BJ Lewis, R Herriot, RN Barker, AD Ormerod	Clinical & Experimental Immunology	2015
Activation of Blood Coagulation in Two Prototypic Autoimmune Skin Diseases: A Possible Link with Thrombotic Risk M Cugno, A Tedeschi, A Borghi, P Bucciarelli, R Asero, L Venegoni, S Griffini, E Grovetti, E Berti, AV Marzano, M Picardo	PloS one	2015
Distinctive Treg associated CCR4-CCL22 expression profile with altered frequency of Th17/Treg cell in the immunopathogenesis of Pemphigus Vulgaris R Asothai, V Anand, D Das, PS Antil, S Khandpur, VK Sharma, A Sharma	Immunobiology	2015
Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome J Plée, SL Jan, J Giustiniani, C Barbe, P Joly, C Bedane, P Vabres, F Truchetet, F Aubin, F Antonicelli, P Bernard	Scientific Reports	2015
Pathophysiology of Autoimmune Bullous Diseases: Nature Versus Nurture E Maverakis, I Bustos, F Patel, R Wilken, FB Patel, H Sultani, C Duong, JJ Zone, SP Raychaudhuri	Indian journal of dermatology	2015
Blistering Diseases DF Murrell		2015
Personalized Treatment Options in Dermatology T Bieber, F Nestle		2015
Pathogenic IgG Antibodies against Desmoglein 3 in Pemphigus Vulgaris Are Regulated by HLA-DRB1*04:02-Restricted T Cells R Eming, T Hennerici, J Backlund, C Feliciani, KC Visconti, S Willenborg, J Wohde, R Holmdahl, G Sonderstrup, M Hertl	Journal of immunology (Baltimore, Md. : 1950)	2014
Molecular diagnosis in autoimmune skin blistering conditions JV Otten, T Hashimoto, M Hertl, AS Payne, C Sitaru	Current molecular medicine	2014
Study of T helper 1 and T helper 2 responses in pemphigus vulgaris patients receiving interferon alpha 2a injections in addition to a standard protocol therapy: a randomized controlled trial MA El-Darouti, RA Hegazy, RM Hay, MS el Hawary, AM Tawdy, MM Fawzy, LA Rashed	Archives of Dermatological Research	2014
Bullous Pemphigoid, Mucous Membrane Pemphigoid and Pemphigus Vulgaris: An Update on Pathobiology L Okon, V Werth	Current Oral Health Reports	2014
Prothrombotic state and impaired fibrinolysis in bullous pemphigoid, the most frequent autoimmune blistering disease AV Marzano, A Tedeschi, I Polloni, C Crosti, M Cugno	Clinical & Experimental Immunology	2013
Bullous pemphigoid: Etiology, pathogenesis, and inducing factors: Facts and controversies AL Schiavo, E Ruocco, G Brancaccio, S Caccavale, V Ruocco, R Wolf	Clinics in Dermatology	2013
Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris KT Amber, P Staropoli, MI Shiman, GW Elgart, M Hertl	Experimental Dermatology	2013
Successful treatment of localized pemphigus foliaceus with topical pimecrolimus G Tyros, K Kalapothakou, E Christofidou, A Kanelleas, PG Stavropoulos	Case Reports in Dermatological Medicine	2013
Enrichment of total serum IgG4 in patients with pemphigus T Funakoshi, L Lunardon, CT Ellebrecht, AR Nagler, CE O'Leary, AS Payne	The British journal of dermatology	2012
Evidence for vitamin D deficiency and increased prevalence of fractures in autoimmune bullous skin diseases: Vitamin D and prevalence of fractures in bullous diseases AV Marzano, V Trevisan, C Eller-Vainicher, E Cairoli, L Marchese, V Morelli, P Beck-Peccoz, C Crosti, I Chiodini	British Journal of Dermatology	2012
Evidence for pathogenicity of autoreactive T cells in autoimmune bullous diseases shown by animal disease models H Ujiie, H Shimizu	Experimental Dermatology	2012
IgG Autoantibodies Against Desmocollin 3 in Pemphigus Sera Induce Loss of Keratinocyte Adhesion D Rafei, R Müller, N Ishii, M Llamazares, T Hashimoto, M Hertl, R Eming	The American Journal of Pathology	2011
Pemphigus autoimmunity: Hypotheses and realities SA Grando	Autoimmunity	2011
Immune functions of the skin C Bangert, PM Brunner, G Stingl	Clinics in Dermatology	2011
Harper's Textbook of Pediatric Dermatology HM Goodyear	Harper's Textbook of Pediatric Dermatology	2011
A glass of red wine to keep vascular disease at bay, but what about pemphigus vulgaris? G Caldarola, C Feliciani	Expert Review of Clinical Immunology	2011
Autoimmune blistering diseases of the skin M Sticherling, C Erfurt-Berge	Autoimmunity Reviews	2011
Rituximab for the treatment of corticosteroid - refractory pemphigus vulgaris with oral and skin manifestations E Craythorne, A Viver, GJ Mufti, S Warnakulasuriya	Journal of Oral Pathology & Medicine	2011
Constructing immunoprofiles to deconstruct disease complexity in pemphigus AA Sinha	Autoimmunity	2011
Chronic methyl mercury poisoning may trigger endemic pemphigus foliaceus “fogo selvagem” MA Robledo	Medical Hypotheses	2011
Pemphigus : revue de la littérature P Joly, C Sin	Annales de Dermatologie et de Vénéréologie	2011
Bioinformatics-Based Predictions of Peptide Binding to Disease-Associated HLA Proteins Suggest Explanation for Shared Autoimmunity JP Glutting, PA Reche, M Fridkis-Hareli	Immunology and Immunogenetics Insights	2011
T and B cells target identical regions of the non-collagenous domain 1 of type VII collagen in epidermolysis bullosa acquisita R Müller, C Dahler, C Möbs, E Wenzel, R Eming, G Messer, A Niedermeier, M Hertl	Clinical Immunology	2010
T cells reactive with the NC16A domain of BP180 are present in vulval lichen sclerosus and lichen planus M Baldo, A Bailey, B Bhogal, RW Groves, G Ogg, F Wojnarowska	Journal of the European Academy of Dermatology and Venereology	2010
Lichen planus pemphigoides, a possible example of epitope spreading MD Mignogna, G Fortuna, S Leuci, L Stasio, E Mezza, E Ruoppo	Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology	2010
From Cell Signaling to Novel Therapeutic Concepts: International Pemphigus Meeting on Advances in Pemphigus Research and Therapy S Getsios, J Waschke, L Borradori, M Hertl, EJ Müller	Journal of Investigative Dermatology	2010
Screening and Analysis of Adsorbents for Pemphigus Autoantibodies H Yamada, A Itoh, Y Hatanaka, M Tsukiji, K Takamori	Therapeutic Apheresis and Dialysis	2010
Human leukocyte antigen genotypes and antibody profiles associated with familial pemphigus in Japanese T YAMAMOTO, K IKEDA, S SASAOKA, O YAMASAKI, W FUJIMOTO, Y AOYAMA, K IWATSUKI	The Journal of Dermatology	2010
Confirmation of a disease model of pemphigus vulgaris: characterization and correlation between disease parameters in 90 mice TL Holm, H Markholst	Experimental Dermatology	2010
Immunofluorescence of the outer root sheath: an aid to diagnosis in pemphigus M Kumaresan, R Rai, V Sandhya	Clinical and Experimental Dermatology	2010
Rituximab Exerts a Dual Effect in Pemphigus Vulgaris BH Thiers	Yearbook of Dermatology and Dermatologic Surgery	2010
Autoimmunity against type VII collagen in inflammatory bowel disease G Hundorfean, MF Neurath, C Sitaru	Journal of Cellular and Molecular Medicine	2009
Antibodies to the Desmoglein 1 Precursor Proprotein but Not to the Mature Cell Surface Protein Cloned from Individuals without Pemphigus J Yamagami, S Kacir, K Ishii, AS Payne, DL Siegel, JR Stanley	Journal of immunology (Baltimore, Md. : 1950)	2009
B-Cell-Directed Therapy for Inflammatory Skin Diseases A Nagel, M Hertl, R Eming	Journal of Investigative Dermatology	2009
Coagulation activation in autoimmune bullous diseases AV Marzano, A Tedeschi, D Spinelli, D Fanoni, C Crosti, M Cugno	Clinical & Experimental Immunology	2009
Reduced numbers of circulating γδ T cells in patients with bullous pemphigoid E Oswald, P Fisch, T Jakob, L Bruckner-Tuderman, SF Martin, A Rensing-Ehl	Experimental Dermatology	2009
Activation of blood coagulation in autoimmune skin disorders M Cugno, A Tedeschi, C Crosti, AV Marzano	Expert Review of Clinical Immunology	2009
Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications AV Marzano, A Tedeschi, D Fanoni, E Bonanni, L Venegoni, E Berti, M Cugno	British Journal of Dermatology	2009
CD28 T-cell costimulatory molecule expression in pemphigus vulgaris M Alecu, C Ursaciuc, M Surcel, G Coman, D Ciotaru, M Dobre	Journal of the European Academy of Dermatology and Venereology	2009
Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study G Marazza, HC Pham, L Schärer, PP Pedrazzetti, T Hunziker, RM Trüeb, D Hohl, P Itin, S Lautenschlager, L Naldi, L Borradori	British Journal of Dermatology	2009
Research in practice: Treatment of autoimmune bullous disorders M Hertl	Journal der Deutschen Dermatologischen Gesellschaft	2009
Neonatal pemphigus in an infant born to a mother with serologic evidence of both pemphigus vulgaris and gestational pemphigoid J Panko, SR Florell, J Hadley, J Zone, K Leiferman, S Vanderhooft	Journal of the American Academy of Dermatology	2009
Middleton's Allergy: Principles and Practice RP Schleimer	Middleton's Allergy: Principles and Practice	2009
Involvement of T H 1/T H 2 Cytokines in the Pathogenesis of Autoimmune Skin Disease— Pemphigus Vulgaris A Satyam, S Khandpur, VK Sharma, A Sharma	Immunological Investigations	2009
Fortschritte der praktischen Dermatologie und Venerologie T Ruzicka, H Wolff, P Thomas, J Prinz		2009
Braun-Falco’s Dermatology WH Burgdorf, G Plewig, HH Wolff, M Landthaler, O Braun-Falco		2009
Rituximab Exerts a Dual Effect in Pemphigus Vulgaris R Eming, A Nagel, S Wolff-Franke, E Podstawa, D Debus, M Hertl	Journal of Investigative Dermatology	2008
The desmosome and pemphigus J Waschke	Histochemistry and Cell Biology	2008
Immunological hotspots analyzed by docking simulations: evidence for a general mechanism in pemphigus vulgaris pathology and transformation JC Tong, AA Sinha	BMC Immunology	2008
Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: A paradigm of human autoimmunity DA Culton, Y Qian, N Li, D Rubenstein, V Aoki, GH Filhio, EA Rivitti, LA Diaz	Journal of Autoimmunity	2008
[B-cell-depleting antibodies in skin diseases] A Nagel, M Hertl, R Eming	Der Hautarzt	2008
Searching for foreign antigens as possible triggering factors of autoimmunity: Torque Teno virus DNA prevalence is elevated in sera of patients with bullous pemphigoid A Blazsek, P Sillo, N Ishii, P Gergely, G Poor, K Preisz, T Hashimoto, M Medvecz, S Kárpáti	Experimental Dermatology	2008
B-Cell Depletion Immunotherapy in Pemphigus: Effects on Cellular and Humoral Immune Responses H Mouquet, P Musette, ML Gougeon, S Jacquot, B Lemercier, A Lim, D Gilbert, I Dutot, JC Roujeau, M D'Incan, C Bedane, F Tron, P Joly	Journal of Investigative Dermatology	2008
Rituximab Immunotherapy in Pemphigus: Therapeutic Effects Beyond B-Cell Depletion G Zambruno, L Borradori	Journal of Investigative Dermatology	2008
Diagnostic Pathways and Clinical Significance of Desquamative Gingivitis LL Russo, S Fedele, R Guiglia, D Ciavarella, LL Muzio, P Gallo, CD Liberto, G Campisi	Journal of Periodontology	2008
Clinical and Molecular Characterization of Autoimmune Bullous Diseases M Hertl, D Zillikens	Journal of Investigative Dermatology	2008
Experimental Extracorporeal Photopheresis Inhibits the Sensitization and Effector Phases of Contact Hypersensitivity via Two Mechanisms: Generation of IL-10 and Induction of Regulatory T Cells A Maeda, A Schwarz, A Bullinger, A Morita, D Peritt, T Schwarz	Journal of immunology (Baltimore, Md. : 1950)	2008
A Perspective of Pemphigus from Bedside and Laboratory-Bench Y Kitajima, Y Aoyama	Clinical Reviews in Allergy & Immunology	2007
Pemphigus: A Complex T Cell-dependent Autoimmune Disorder Leading to Acantholysis C Veldman, C Feliciani	Clinical Reviews in Allergy & Immunology	2007
A new passive transfer animal model of bullous pemphigoid AM Powell	Expert Review of Dermatology	2007
Experimental models of epidermolysis bullosa acquisita C Sitaru	Experimental Dermatology	2007
The CD40/CD40 ligand system is involved in the pathogenesis of pemphigus M Caproni, E Antiga, D Torchia, W Volpi, E Bianco, A Cappetti, C Feliciani, P Fabbri	Clinical Immunology	2007
Detection of low avidity desmoglein 3-reactive T cells in pemphigus vulgaris using HLA-DRβ1⁎0402 tetramers C Veldman, R Eming, S Wolff-Franke, G Sonderstrup, WW Kwok, M Hertl	Clinical Immunology	2007
Genotyping of HLA-I and HLA-II alleles in Chinese patients with paraneoplastic pemphigus Q Liu, DF Bu, D Li, XJ Zhu	British Journal of Dermatology	2007
Variations in Serum Hemoglobin, Albumin, and Electrolytes in Patients Receiving Intravenous Immunoglobulin Therapy MD Mignogna, G Fortuna, E Ruoppo, D Adamo, S Leuci, S Fedele	American Journal of Clinical Dermatology	2007
Pemphigus vulgaire évolutif sous corticoïdes et immunosuppresseurs: rémission sous rituximab. Deux observations C Borel, F Launay, C Garrouste, L Astudillo, J Bazex, P Arlet, C Paul, R Viraben, L Sailler	La Revue de Médecine Interne	2007
Increased Serum Levels of Circulating CD40 Ligand in Patients with Bullous Pemphigoid: Preliminary Results R Watanabe, N Ishiura, H Nakashima, N Yazawa, Y Kuwano, Y Tada, H Okochi, M Fujimoto, K Tamaki	Dermatology	2007
Epidermolysis Bullosa Acquisita following Bullous Pemphigoid, Successfully Treated with the Anti-CD20 Monoclonal Antibody Rituximab N Wallet-Faber, N Franck, F Batteux, C Mateus, D Gilbert, A Carlotti, MF Avril, N Dupin	Dermatology	2007
Biologics in General Medicine WH Boehncke, HH Radeke		2007
Nothing but skin and bone FP Ross, AM Christiano	Journal of Clinical Investigation	2006
Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just ‘witnesses of disease'? R Paus, M Amagai, AR Ahmed, Y Kitajima, JC Bystryn, Y Milner, R Gniadecki, M Hertl, C Pincelli, M Fridkis-Hareli, Y Aoyama, M Frušić-Zlotkin, E Müller, M David, D Mimouni, D Vind-Kezunovic, B Michel, M Mahoney, S Grando	Experimental Dermatology	2006
Commentary 3 M Hertl	Experimental Dermatology	2006
Who is really in control of skin immunity underphysiologicalcircumstances - lymphocytes, dendritic cells or keratinocytes? R Paus, JM Schröder, K Reich, K Kabashima, FT Liu, N Romani, M Metz, A Kerstan, PH Lee, K Loser, MP Schön, M Maurer, P Stoitzner, S Beissert, Y Tokura, RL Gallo, K Reich	Experimental Dermatology	2006
Autoimmune Diseases of the Skin M Hertl		2005
Bullous pemphigoid D Mimouni, HC Nousari	Dermatologic Therapy	2002
Pruritus J Martin	International Journal of Dermatology	1985

Advertisement